Med-IQ CME: oHCM: Changing the Paradigm for Clinicians and Keeping Patients Informed
In this #CME #MedX, get the latest guidance on managing hypertrophic cardiomyopathy (HCM), including confirming an obstructive HCM (oHCM) diagnosis, integrating recent clinical information on cardiac myosin inhibitor treatments, and addressing patients’ concerns and questions about living with HCM.
Cost: Free
View Offer chevron_rightKey Features
The latest guidance on managing HCM, including integrating recent clinical information on cardiac myosin inhibitor treatments.
Topics Covered
HCM and oHCM diagnosis and treatment
Learning Objectives
1. Characterize the signs and symptoms of oHCM
2. Describe the latest information about mavacamten and aficamten
3. Customize conversations with patients to address their concerns and fears about oHCM
Target Audience
This activity is intended for cardiology and primary care clinicians including physicians, physician assistants, nurse practitioners, and nurses who provide care for people with HCM.
Additional credit info
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Med-IQ designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.